1740. Healthcare Providers’ Preferences for Pediatric Pneumococcal Vaccination Recommendations in the United States

BACKGROUND: A 20-valent pneumococcal conjugate vaccine (PCV20) was recently licensed for use in children by the United States (US) Food and Drug Administration. PCV20 includes 5 and 7 more serotypes than the 15- (PCV15) and 13-valent (PCV13) vaccines, respectively. This study assessed healthcare pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Vietri, Jeffrey T, Myers, Kelley H, Huang, Liping, Snow, Vincenza, Hauber, Brett, Arguedas, Adriano, Cane, Alejandro D, Tort, Maria J, Pierce, Anna, Poulos, Christine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10679108/
http://dx.doi.org/10.1093/ofid/ofad500.1571

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10679108/
http://dx.doi.org/10.1093/ofid/ofad500.1571

Ejemplares similares